These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 23593689)

  • 1. Eculizumab. A less burdensome treatment for atypical haemolytic uraemic syndrome?
    Prescrire Int; 2013 Mar; 22(136):68. PubMed ID: 23593689
    [No Abstract]   [Full Text] [Related]  

  • 2. Eculizumab in the treatment of atypical haemolytic uraemic syndrome and other complement-mediated renal diseases.
    Nester CM; Brophy PD
    Curr Opin Pediatr; 2013 Apr; 25(2):225-31. PubMed ID: 23486421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombotic microangiopathy: eculizumab for atypical haemolytic uraemic syndrome: what next?
    Fakhouri F; Frémeaux-Bacchi V
    Nat Rev Nephrol; 2013 Sep; 9(9):495-6. PubMed ID: 23917793
    [No Abstract]   [Full Text] [Related]  

  • 4. [Eculizumab: effectiveness of a shortened dosing schedule in the treatment of atypical haemolytic uremic syndrome of unknown origin].
    Beye F; Malbranche C; Tramecon D; Pernot C; Zanetta G; Mousson C; Guignard MH; Lazzarotti A
    Therapie; 2013; 68(2):119-22. PubMed ID: 23773354
    [No Abstract]   [Full Text] [Related]  

  • 5. Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome.
    Legendre CM; Licht C; Muus P; Greenbaum LA; Babu S; Bedrosian C; Bingham C; Cohen DJ; Delmas Y; Douglas K; Eitner F; Feldkamp T; Fouque D; Furman RR; Gaber O; Herthelius M; Hourmant M; Karpman D; Lebranchu Y; Mariat C; Menne J; Moulin B; Nürnberger J; Ogawa M; Remuzzi G; Richard T; Sberro-Soussan R; Severino B; Sheerin NS; Trivelli A; Zimmerhackl LB; Goodship T; Loirat C
    N Engl J Med; 2013 Jun; 368(23):2169-81. PubMed ID: 23738544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of the postpartum atypical hemolytic uremic syndrome with eculizumab.
    Zschiedrich S; Prager EP; Kuehn EW
    Ann Intern Med; 2013 Jul; 159(1):76. PubMed ID: 23817717
    [No Abstract]   [Full Text] [Related]  

  • 7. Novel aspects of atypical haemolytic uraemic syndrome and the role of eculizumab.
    Verhave JC; Wetzels JF; van de Kar NC
    Nephrol Dial Transplant; 2014 Sep; 29 Suppl 4():iv131-41. PubMed ID: 25165180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eculizumab for the treatment of two recurrences of atypical hemolytic uremic syndrome in a kidney allograft.
    Alachkar N; Bagnasco SM; Montgomery RA
    Transpl Int; 2012 Aug; 25(8):e93-5. PubMed ID: 22591029
    [No Abstract]   [Full Text] [Related]  

  • 9. A new era in the diagnosis and treatment of atypical haemolytic uraemic syndrome.
    Westra D; Wetzels JF; Volokhina EB; van den Heuvel LP; van de Kar NC
    Neth J Med; 2012 Apr; 70(3):121-9. PubMed ID: 22516576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Eculizumab for atypical hemolytic uremic syndrome in newborn: a case report].
    Alonso-Triana YM; Perrino MJ
    Farm Hosp; 2015 Jul; 39(4):217-8. PubMed ID: 26276740
    [No Abstract]   [Full Text] [Related]  

  • 11. Eculizumab for the treatment of pregnancy-related atypical hemolytic uremic syndrome.
    Cañigral C; Moscardó F; Castro C; Pajares A; Lancharro A; Solves P; de la Rubia J; Carpio N; Sanz MA
    Ann Hematol; 2014 Aug; 93(8):1421-2. PubMed ID: 24306089
    [No Abstract]   [Full Text] [Related]  

  • 12. Eculizumab in atypical hemolytic-uremic syndrome.
    Legendre CM; Licht C; Loirat C
    N Engl J Med; 2013 Oct; 369(14):1379-80. PubMed ID: 24088105
    [No Abstract]   [Full Text] [Related]  

  • 13. Eculizumab in atypical hemolytic-uremic syndrome.
    Ring T
    N Engl J Med; 2013 Oct; 369(14):1377-8. PubMed ID: 24088106
    [No Abstract]   [Full Text] [Related]  

  • 14. Eculizumab in atypical hemolytic-uremic syndrome.
    Amadio A; Tejani AM
    N Engl J Med; 2013 Oct; 369(14):1378. PubMed ID: 24088107
    [No Abstract]   [Full Text] [Related]  

  • 15. Eculizumab in atypical hemolytic-uremic syndrome.
    Kistler AD
    N Engl J Med; 2013 Oct; 369(14):1378. PubMed ID: 24088108
    [No Abstract]   [Full Text] [Related]  

  • 16. Eculizumab in atypical hemolytic-uremic syndrome.
    Tanimoto T; Oshima Y; Kami M
    N Engl J Med; 2013 Oct; 369(14):1378-9. PubMed ID: 24088109
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy of eculizumab in the treatment of recurrent atypical hemolytic-uremic syndrome after renal transplantation.
    Larrea CF; Cofan F; Oppenheimer F; Campistol JM; Escolar G; Lozano M
    Transplantation; 2010 Apr; 89(7):903-4. PubMed ID: 20386298
    [No Abstract]   [Full Text] [Related]  

  • 18. More on eculizumab for congenital atypical hemolytic-uremic syndrome.
    Shin JI; Lee JS
    N Engl J Med; 2009 May; 360(20):2142-3; author reply 2143. PubMed ID: 19439754
    [No Abstract]   [Full Text] [Related]  

  • 19. Eculizumab for congenital atypical hemolytic-uremic syndrome.
    Gruppo RA; Rother RP
    N Engl J Med; 2009 Jan; 360(5):544-6. PubMed ID: 19179329
    [No Abstract]   [Full Text] [Related]  

  • 20. Eculizumab in the treatment of atypical hemolytic uremic syndrome in infants.
    Ariceta G; Arrizabalaga B; Aguirre M; Morteruel E; Lopez-Trascasa M
    Am J Kidney Dis; 2012 May; 59(5):707-10. PubMed ID: 22196848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.